179 related articles for article (PubMed ID: 15499298)
1. Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas.
Ferrari L; Seregni E; Aliberti G; Martinetti A; Pallotti F; Villano C; Lucignani G; Bombardieri E
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):237-42. PubMed ID: 15499298
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
[TBL] [Abstract][Full Text] [Related]
3. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
[TBL] [Abstract][Full Text] [Related]
4. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
6. Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.
Weightman DR; Mallick UK; Fenwick JD; Perros P
Cancer; 2003 Jul; 98(1):41-7. PubMed ID: 12833453
[TBL] [Abstract][Full Text] [Related]
7. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
8. Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457).
Lee JI; Kim JY; Choi JY; Kim HK; Jang HW; Hur KY; Kim JH; Kim KW; Chung JH; Kim SW
Head Neck; 2010 Sep; 32(9):1161-6. PubMed ID: 20029980
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity human thyroglobulin (hTG) immunoradiometric assay in the follow-up of patients with differentiated thyroid cancer.
Giovanella L; Ceriani L
Clin Chem Lab Med; 2002 May; 40(5):480-4. PubMed ID: 12113292
[TBL] [Abstract][Full Text] [Related]
10. [The value of a new IRMA for determining thyroglobulin].
Heinze HG; Rall M
Nuklearmedizin; 1992 Oct; 31(5):172-7. PubMed ID: 1465354
[TBL] [Abstract][Full Text] [Related]
11. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
13. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
Li D; Butt A; Clarke S; Swaminathana R
Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
[TBL] [Abstract][Full Text] [Related]
14. Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin.
Morgenthaler NG; Froehlich J; Rendl J; Willnich M; Alonso C; Bergmann A; Reiners C
Clin Chem; 2002 Jul; 48(7):1077-83. PubMed ID: 12089177
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of a new thyroglobulin immunoradiometric assay in the follow-up of differentiated thyroid carcinoma].
Sahlmann CO; Schreivogel I; Angerstein C; Siefker U; Lehmann K; Altenvoerde G; Hüfner M; Meller J
Nuklearmedizin; 2003; 42(2):71-7. PubMed ID: 12695789
[TBL] [Abstract][Full Text] [Related]
16. Does a highly sensitive thyroglobulin (Tg) assay change the clinical management of low-risk patients with thyroid cancer with Tg on T4 < 1 ng/ml determined by traditional assays?
Rosario PW; Purisch S
Clin Endocrinol (Oxf); 2008 Mar; 68(3):338-42. PubMed ID: 17850379
[TBL] [Abstract][Full Text] [Related]
17. [Inappropriately undetectable thyroglobulin after exclusion of interference from thyroglobulin antibodies].
Munier P; Courtier F; Barrial K; Chikh K; Claustrat F; Le Bricon T; Bronner J; Sanabria E
Ann Biol Clin (Paris); 2011; 69(6):721-5. PubMed ID: 22123574
[TBL] [Abstract][Full Text] [Related]
18. Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests.
Bourrel F; Hoff M; Regis H; Courrière P; Caron P
Clin Chem Lab Med; 1998 Sep; 36(9):725-30. PubMed ID: 9804398
[TBL] [Abstract][Full Text] [Related]
19. Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact.
Iervasi A; Iervasi G; Carpi A; Zucchelli GC
Biomed Pharmacother; 2006 Sep; 60(8):414-24. PubMed ID: 16959467
[TBL] [Abstract][Full Text] [Related]
20. Assay bias may invalidate decision limits and affect comparability of serum thyroglobulin assay methods: an approach to reduce interpretation differences.
Ross HA; Netea-Maier RT; Schakenraad E; Bravenboer B; Hermus AR; Sweep FC
Clin Chim Acta; 2008 Aug; 394(1-2):104-9. PubMed ID: 18498765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
